로딩 중…
지수 로딩 중…
Immunovant, Inc.
IMVT· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$35.34+1.82%
2026-06-18
Price Chart
Immunovant, Inc.+122.82%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $7.26B |
| Revenue | $0.00 |
| Net Income | $-506M |
| Total Assets | $957M |
| Net Assets | $853M |
| Value | |
| P/B | 8.51x |
| FCF Yield | -5.61% |
| Profitability | |
| ROE | -59.30% |
| ROA | -52.83% |
| Financial Health | |
| Debt Ratio | 12.25% |
| Total Debt | $72000.00 |
| FCF | $-407M |
| Cash | $902M |
| Current Ratio | 9.09x |
| Performance | |
| 1Y Return | 122.82% |
| 1M Return | 34.42% |
| From 52W High | -2.59% |
| 1Y MDD | -21.82% |
| Trading | |
| Volume | 3,198,542 shares |
| Trading Value | $113M |
| Per Share | |
| EPS | $-2.56 |
| BPS | $5.43 |